Observational analysis finds survival benefits from avelumab in metastatic urothelial carcinoma patients, suggesting that tumor site and prior surgery may influence outcomes.
BJU InternationalEarly View Research Letter Maintenance avelumab in metastatic urothelial carcinoma: do tumour site and previous surgery matter? Ruslan Zukov, Ruslan Zukov V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, RussiaSearch for more papers by this authorYana Gridneva, Yana Gridneva Oncological Center No.1 of Moscow City Hospital Named After S.S. Yudin, Moscow, RussiaSearch for more papers by this authorYulia Anzhiganova, Yulia Anzhiganova A.I. Kryzhanovsky Krasnoyarsk Regional Cancer Center, Krasnoyarsk, RussiaSearch for more papers by this authorAlexander Sultanbaev, Alexander Sultanbaev Republican Clinical Oncology Dispensary, Ufa, RussiaSearch for more papers by this authorMark Gluzman, Mark Gluzman Saint-Petersburg State University, Saint-Petersburg, RussiaSearch for more papers by this authorAnastasia Mochalova, Anastasia Mochalova Clinical Hospital #1, Medsi Otradnoe, Moscow, RussiaSearch for more papers by this authorAlexey Shkurat, Alexey Shkurat orcid.org/0000-0003-0776-724X Department of Medical Oncology, SBHI Leningrad Regional Clinical Hospital, Saint-Petersburg, RussiaSearch for more papers by this authorEdgar Israelyan, Edgar Israelyan N.N. Blokhin National Medical Research Center of Oncology, Moscow, RussiaSearch for more papers by this authorElvira Parsadanova, Elvira Parsadanova Sakhalin Regional Clinical Oncology Dispensary, Yuzhno-Sakhalinsk, RussiaSearch for more papers by this authorYulia Murzina, Yulia Murzina Birobidzhan Regional Cancer Center, Birobidzhan, RussiaSearch for more papers by this authorAleksei Ivanov, Aleksei Ivanov Center for Immunotherapy and Targeted Therapy, Moscow, RussiaSearch for more papers by this authorAlexey Kalpinskiy, Alexey Kalpinskiy P.A. Herzen Moscow Oncological Research Institute, Moscow, RussiaSearch for more papers by this authorOlesia Stativko, Olesia Stativko Oncological Center No.1 of Moscow City Hospital Named After S.S. Yudin, Moscow, RussiaSearch for more papers by this authorVladislav Petkau, Vladislav Petkau Sverdlovskiy Regional Oncological Dispensary, Ekaterinburg, RussiaSearch for more papers by this authorElena Karabina, Elena Karabina Tula Regional Oncology Dispensary, Tula, RussiaSearch for more papers by this authorArtyom Kеln, Artyom Kеln Tyumen State Medical University, Tyumen, RussiaSearch for more papers by this authorNatalya Tovbik, Natalya Tovbik Amur Regional Oncology Center, Blagoveshchensk, RussiaSearch for more papers by this authorSufia Safina, Sufia Safina Republican Dispensary of Tatarstan, Kazan, RussiaSearch for more papers by this authorMaria Turganova, Maria Turganova Novosibirsk Regional Cancer Center, Novosibirsk, RussiaSearch for more papers by this authorEvgeny Kopyltsov, Evgeny Kopyltsov Omsk Regional Cancer Center, Omsk, RussiaSearch for more papers by this authorVarvara Bragina, Varvara Bragina Tver Regional Cancer Center, Tver, RussiaSearch for more papers by this authorOlga Novikova, Olga Novikova Khabarovsk Regional Cancer Center, Khabarovsk, RussiaSearch for more papers by this authorAndrei Lebedinets, Andrei Lebedinets Department of Medical Oncology, SBHI Leningrad Regional Clinical Hospital, Saint-Petersburg, RussiaSearch for more papers by this authorVladislav Vodolazskiy, Vladislav Vodolazskiy orcid.org/0000-0002-6839-5411 Omsk Regional Cancer Center, Omsk, RussiaSearch for more papers by this authorAlexey Rumyantsev, Alexey Rumyantsev N.N. Blokhin National Medical Research Center of Oncology, Moscow, RussiaSearch for more papers by this authorIlya Pokataev, Ilya Pokataev Oncological Center No.1 of Moscow City Hospital Named After S.S. Yudin, Moscow, RussiaSearch for more papers by this authorRashida Orlova, Rashida Orlova Saint-Petersburg State University, Saint-Petersburg, RussiaSearch for more papers by this authorMaria Volkova, Maria Volkova Oncological Center No.1 of Moscow City Hospital Named After S.S. Yudin, Moscow, RussiaSearch for more papers by this authorIlya Tsimafeyeu, Corresponding Author Ilya Tsimafeyeu [email protected] orcid.org/0000-0002-7357-0392 Bureau for Cancer Research – Moscow office, Moscow, Russia Correspondence: Ilya Tsimafeyeu, BUCARE (Bureau of Cancer Research) – Moscow Office, Mayakovskogo pereulok 2, Moscow 109147, Russia. e-mail: [email protected]Search for more papers by this author Ruslan Zukov, Ruslan Zukov V.F. Voyno-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, RussiaSearch for more papers by this authorYana Gridneva, Yana Gridneva Oncological Center No.1 of Moscow City Hospital Named After S.S. Yudin, Moscow, RussiaSearch for more papers by this authorYulia Anzhiganova, Yulia Anzhiganova A.I. Kryzhanovsky Krasnoyarsk Regional Cancer Center, Krasnoyarsk, RussiaSearch for more papers by this authorAlexander Sultanbaev, Alexander Sultanbaev Republican Clinical Oncology Dispensary, Ufa, RussiaSearch for more papers by this authorMark Gluzman, Mark Gluzman Saint-Petersburg State University, Saint-Petersburg, RussiaSearch for more papers by this authorAnastasia Mochalova, Anastasia Mochalova Clinical Hospital #1, Medsi Otradnoe, Moscow, RussiaSearch for more papers by this authorAlexey Shkurat, Alexey Shkurat orcid.org/0000-0003-0776-724X Department of Medical Oncology, SBHI Leningrad Regional Clinical Hospital, Saint-Petersburg, RussiaSearch for more papers by this authorEdgar Israelyan, Edgar Israelyan N.N. Blokhin National Medical Research Center of Oncology, Moscow, RussiaSearch for more papers by this authorElvira Parsadanova, Elvira Parsadanova Sakhalin Regional Clinical Oncology Dispensary, Yuzhno-Sakhalinsk, RussiaSearch for more papers by this authorYulia Murzina, Yulia Murzina Birobidzhan Regional Cancer Center, Birobidzhan, RussiaSearch for more papers by this authorAleksei Ivanov, Aleksei Ivanov Center for Immunotherapy and Targeted Therapy, Moscow, RussiaSearch for more papers by this authorAlexey Kalpinskiy, Alexey Kalpinskiy P.A. Herzen Moscow Oncological Research Institute, Moscow, RussiaSearch for more papers by this authorOlesia Stativko, Olesia Stativko Oncological Center No.1 of Moscow City Hospital Named After S.S. Yudin, Moscow, RussiaSearch for more papers by this authorVladislav Petkau, Vladislav Petkau Sverdlovskiy Regional Oncological Dispensary, Ekaterinburg, RussiaSearch for more papers by this authorElena Karabina, Elena Karabina Tula Regional Oncology Dispensary, Tula, RussiaSearch for more papers by this authorArtyom Kеln, Artyom Kеln Tyumen State Medical University, Tyumen, RussiaSearch for more papers by this authorNatalya Tovbik, Natalya Tovbik Amur Regional Oncology Center, Blagoveshchensk, RussiaSearch for more papers by this authorSufia Safina, Sufia Safina Republican Dispensary of Tatarstan, Kazan, RussiaSearch for more papers by this authorMaria Turganova, Maria Turganova Novosibirsk Regional Cancer Center, Novosibirsk, RussiaSearch for more papers by this authorEvgeny Kopyltsov, Evgeny Kopyltsov Omsk Regional Cancer Center, Omsk, RussiaSearch for more papers by this authorVarvara Bragina, Varvara Bragina Tver Regional Cancer Center, Tver, RussiaSearch for more papers by this authorOlga Novikova, Olga Novikova Khabarovsk Regional Cancer Center, Khabarovsk, RussiaSearch for more papers by this authorAndrei Lebedinets, Andrei Lebedinets Department of Medical Oncology, SBHI Leningrad Regional Clinical Hospital, Saint-Petersburg, RussiaSearch for more papers by this authorVladislav Vodolazskiy, Vladislav Vodolazskiy orcid.org/0000-0002-6839-5411 Omsk Regional Cancer Center, Omsk, RussiaSearch for more papers by this authorAlexey Rumyantsev, Alexey Rumyantsev N.N. Blokhin National Medical Research Center of Oncology, Moscow, RussiaSearch for more papers by this authorIlya Pokataev, Ilya Pokataev Oncological Center No.1 of Moscow City Hospital Named After S.S. Yudin, Moscow, RussiaSearch for more papers by this authorRashida Orlova, Rashida Orlova Saint-Petersburg State University, Saint-Petersburg, RussiaSearch for more papers by this authorMaria Volkova, Maria Volkova Oncological Center No.1 of Moscow City Hospital Named After S.S. Yudin, Moscow, RussiaSearch for more papers by this authorIlya Tsimafeyeu, Corresponding Author Ilya Tsimafeyeu [email protected] orcid.org/0000-0002-7357-0392 Bureau for Cancer Research – Moscow office, Moscow, Russia Correspondence: Ilya Tsimafeyeu, BUCARE (Bureau of Cancer Research) – Moscow Office, Mayakovskogo pereulok 2, Moscow 109147, Russia. e-mail: [email protected]Search for more papers by this author First published: 28 August 2025 https://doi.org/10.1111/bju.16921Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookxLinkedInRedditWechatBluesky No abstract is available for this article. References 1Rouprêt M, Babjuk M, Compérat E et al. European Association of Urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update. Eur Urol 2015; 68: 868–879 10.1016/j.eururo.2015.06.044 PubMed Web of Science® Google Scholar 2Shatkovskaya O, Kaidarova D, Ongarbayev B, Sagi M, Tsimafeyeu I. Five-year overall survival of patients with advanced bladder cancer in Kazakhstan: OSURK registry study. Am J Clin Exp Urol 2023; 11: 542–548 PubMed Web of Science® Google Scholar 3Favaretto RL, Shariat SF, Chade DC et al. The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol 2010; 58: 574–580 10.1016/j.eururo.2010.07.003 PubMed Web of Science® Google Scholar 4Necchi A, Raggi D, Gallina A et al. Impact of molecular subtyping and immune infiltration on pathological response and outcome following Neoadjuvant Pembrolizumab in muscle-invasive bladder cancer. Eur Urol 2020; 77: 701–710 10.1016/j.eururo.2020.02.028 CAS PubMed Web of Science® Google Scholar 5Bamias A, Tzannis K, Harshman LC et al. Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a retrospective international study of invasive/advanced cancer of the Urothelium (RISC). Ann Oncol 2018; 29: 361–369 10.1093/annonc/mdx692 CAS PubMed Web of Science® Google Scholar 6Abufaraj M, Dalbagni G, Daneshmand S et al. The role of surgery in metastatic bladder cancer: a systematic review. Eur Urol 2018; 73: 543–557 10.1016/j.eururo.2017.09.030 PubMed Web of Science® Google Scholar 7Bhalla S, Pfail J, Ghodoussipour S. Is there a role for surgery in the treatment of metastatic urothelial carcinoma? J Clin Med 2024; 13: 7498 10.3390/jcm13247498 CAS PubMed Google Scholar 8Tsimafeyeu I, Gridneva Y, Sultanbaev A et al. Maintenance therapy with Avelumab for patients with metastatic urothelial carcinoma: a real-world, Ambispective RAVE-bladder study. Cancer Med 2025; 14: e70636 10.1002/cam4.70636 CAS PubMed Web of Science® Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation
No takes yet. Share an insight, caveat, or question.
Зуков et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: